跳至主要内容
临床试验/NCT06861491
NCT06861491撤回不适用

Student Pharmacist Intervention on Type 2 Diabetes Management in Older Adult Populations

University of California, San Francisco0 个研究点目标入组 200 人开始时间: 2025年4月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
撤回
入组人数
200
主要终点
Blood glucose control

研究概览

简要总结

This study is being done to assess the impact of student pharmacist involvement on blood glucose control through non-pharmacological interventions in people of Asian and Asian descent over the age of 50 with type 2 diabetes. This study team is trying to advance the field of pharmacy and expand the roles of student pharmacists.

详细描述

This study aims to assess the clinical impact of student pharmacist-led interventions on glycemic control in adult populations. This study will specifically target adults aged 50 years and older of Asian or Asian-descent with diagnosed type 2 diabetes, residing in San Francisco. The goal of the study is to demonstrate the utility of pharmacy students in a community setting on chronic disease management through patient-specific education and interventions. The aims of this study are to compare glycemic control in patients with type 2 diabetes who receive continuous assessment and non-pharmacological counseling from student pharmacists versus those who do not. Specifically, this study will evaluate:

  1. The impact of student pharmacist assessments and personalized recommendations on diet, exercise, and adherence to treatment regimens, and their lasting effects on blood glucose control.
  2. If participants perceived any value and effect of student pharmacist involvement in managing chronic diseases.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Adults ≥ 50 years old
  • •Asian or Asian-descent
  • •Diagnosed with T2DM
  • •A1C >7.0% (uncontrolled)
  • •Take blood glucose measurements as prescribed by their physician, or consistently (defined as missing no more than 1 reading from their regular routine).

排除标准

  • •Age < 50 years old
  • •Not diagnosed with type 2 diabetes, or have diagnoses such as type 1 diabetes, gestational diabetes, or medication induced diabetes
  • •Patients that are on medications that affect glycemic control
  • •Corticosteroids
  • •First-generation antipsychotics (e.g. chlorpromazine, perphenazine, phenothiazines)
  • •Immunosuppressants (e.g. tacrolimus, cyclosporine)
  • •Experiencing acute disease states
  • •Recent surgery/hospitalized within the last 3 months
  • •Active infections
  • •Non-adherence to blood glucose monitoring (defined as missing > 1 reading from their regular routine or not taking readings as prescribed by their doctor)
  • •Patients with late stage T2DM requiring insulin therapy
  • •Diagnosed with cancer, end-stage renal disease, end-stage liver disease
  • •Received any organ transplant

研究组 & 干预措施

Control

No Intervention

Student pharmacists will collect data on participants, but will not provide recommendations on non-pharmacological management. However, they will provide online resources on diabetes management if prompted.

Non-pharmacological intervention and education by student pharmacists

Experimental

Student pharmacists will provide non-pharmacological recommendations to participants about lifestyle modifications, including exercise and diet, as well as provide information about current medications the participant is taking.

干预措施: Non-pharmacological (Behavioral)

结局指标

主要结局

Blood glucose control

时间窗: Up to 12 months

This will assess the average blood glucose change over the course of the study.

A1C

时间窗: Up to 12 months

To assess effect of student pharmacist non-pharmacological intervention on A1C levels

次要结局

  • Utilization of Questionnaires to assess Participant Perceptions of Student Pharmacist Involvement on Chronic Disease Management(Up to 12 months)
  • Utilization of Questionnaires to assess Comprehension of Diabetes Management(Up to 12 months)

研究者

申办方类型
Other
责任方
Sponsor

相似试验

Student Pharmacist Non-Pharmacological Intervention... | 临床试验